Los Angeles Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-144,269
| Closed | -$268K | – | 1318 |
|
|
2022
Q2 | $268K | Buy |
144,269
+1,722
| +1% | +$3.2K | ﹤0.01% | 1182 |
|
|
2022
Q1 | $298K | Buy |
142,547
+23,680
| +20% | +$49.5K | ﹤0.01% | 1241 |
|
|
2021
Q4 | $468K | Sell |
118,867
-332
| -0.3% | -$1.31K | ﹤0.01% | 1041 |
|
|
2021
Q3 | $573K | Buy |
119,199
+60,950
| +105% | +$293K | ﹤0.01% | 991 |
|
|
2021
Q2 | $267K | Buy |
+58,249
| New | +$267K | ﹤0.01% | 1428 |
|
|
2015
Q2 | – | Sell |
-2,584
| Closed | -$17K | – | 1234 |
|
|
2015
Q1 | $17K | Hold |
2,584
| – | – | ﹤0.01% | 1204 |
|
|
2014
Q4 | $16K | Hold |
2,584
| – | – | ﹤0.01% | 1105 |
|
|
2014
Q3 | $26K | Sell |
2,584
-294
| -10% | -$2.96K | ﹤0.01% | 1057 |
|
|
2014
Q2 | $32K | Sell |
2,878
-36,855
| -93% | -$410K | ﹤0.01% | 1187 |
|
|
2014
Q1 | $481K | Buy |
+39,733
| New | +$481K | 0.01% | 891 |
|